Nek9 activators belong to a distinct chemical class known for their pivotal role in cellular processes, particularly in the context of cell cycle regulation and mitotic progression. Nek9, or NIMA (never in mitosis gene a)-related kinase 9, is a member of the Nek family of serine/threonine kinases. These activators specifically target and modulate the activity of Nek9, thereby exerting influence over its downstream signaling pathways. Nek9 itself acts as a critical orchestrator during mitosis, playing a key role in centrosome duplication and separation. The activation of Nek9, facilitated by these specialized compounds, triggers a cascade of events that contribute to the fine-tuned coordination of cellular processes.
Nek9 activators typically possess unique chemical moieties that enable them to interact selectively with the catalytic domain of Nek9. This interaction enhances the kinase's enzymatic activity, resulting in the phosphorylation of specific substrates involved in mitotic progression. The regulatory functions of Nek9, coupled with the precise modulation induced by these activators, highlight the intricate nature of cellular control mechanisms. Understanding the structural basis of Nek9 activation and its subsequent impact on cellular events provides valuable insights into the fundamental processes governing cell division. As researchers delve deeper into the molecular intricacies of Nek9 activators, their potential applications in elucidating the complexities of cell cycle dynamics continue to unfold, shedding light on novel avenues for further exploration in cell biology and related fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is known to regulate cell differentiation and proliferation, processes in which Nek9 is involved. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel (Taxol) stabilizes microtubules, and since Nek9 is involved in mitotic spindle formation, it can indirectly affect Nek9 activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule dynamics, thereby influencing mitotic processes controlled by Nek9. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that can interact with the same pathways as Nek9, thereby indirectly affecting its activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can affect various signaling pathways involving Nek9. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, potentially upregulating kinase activity, including Nek9. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can influence pathways that Nek9 is involved in. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, impacting DNA replication and potentially affecting processes where Nek9 is involved. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine disrupts microtubule assembly, potentially influencing mitotic processes controlled by Nek9. | ||||||